【COVID-19患者皮肤表现与荨麻疹密切相关】。

Q3 Medicine
Mario Sánchez-Borges, Sandra Nora González-Díaz, José Antonio Ortega-Martell, María Isabel Rojo-Gutiérrez, Ignacio Javier Ansotegui-Zubeldia
{"title":"【COVID-19患者皮肤表现与荨麻疹密切相关】。","authors":"Mario Sánchez-Borges,&nbsp;Sandra Nora González-Díaz,&nbsp;José Antonio Ortega-Martell,&nbsp;María Isabel Rojo-Gutiérrez,&nbsp;Ignacio Javier Ansotegui-Zubeldia","doi":"10.29262/ram.v658i2.841","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To describe the most frequent dermatological conditions observed in COVID-19 patients and to determine whether their presence could be used to establish an early diagnosis or to predict the progression of the infection.</p><p><strong>Methods: </strong>There was a review in PubMed/MEDLINE and EMBASE of all the articles that had been published between January 1st and November 1st, 2020, with the search terms focused on \"SARS-CoV-2\", \"COVID-19\" and \"Skin diseases\".</p><p><strong>Results: </strong>Eighty three studies met the inclusion criteria. Skin lesions have been reported in 0.2 % of the patients. The most frequently reported dermatoses were: maculopapular/ morbilliform rashes, urticaria and angioedema, chilblain-like acral pattern, and vesicular lesions. Among researchers, there are differences of opinion about a possible diagnostic or prognostic value of the skin diseases that are associated to the infection.</p><p><strong>Conclusions: </strong>It is advisable to consider the diagnosis of SARS-CoV-2 infection in patients who call the doctor for skin lesions, urticaria, or angioedema, with or without other symptoms of the infection, especially if there is a previous history of recent exposure to other infected subjects.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 2","pages":"112-116"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Cutaneous manifestations in patients with COVID-19 with significant attention to urticaria].\",\"authors\":\"Mario Sánchez-Borges,&nbsp;Sandra Nora González-Díaz,&nbsp;José Antonio Ortega-Martell,&nbsp;María Isabel Rojo-Gutiérrez,&nbsp;Ignacio Javier Ansotegui-Zubeldia\",\"doi\":\"10.29262/ram.v658i2.841\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To describe the most frequent dermatological conditions observed in COVID-19 patients and to determine whether their presence could be used to establish an early diagnosis or to predict the progression of the infection.</p><p><strong>Methods: </strong>There was a review in PubMed/MEDLINE and EMBASE of all the articles that had been published between January 1st and November 1st, 2020, with the search terms focused on \\\"SARS-CoV-2\\\", \\\"COVID-19\\\" and \\\"Skin diseases\\\".</p><p><strong>Results: </strong>Eighty three studies met the inclusion criteria. Skin lesions have been reported in 0.2 % of the patients. The most frequently reported dermatoses were: maculopapular/ morbilliform rashes, urticaria and angioedema, chilblain-like acral pattern, and vesicular lesions. Among researchers, there are differences of opinion about a possible diagnostic or prognostic value of the skin diseases that are associated to the infection.</p><p><strong>Conclusions: </strong>It is advisable to consider the diagnosis of SARS-CoV-2 infection in patients who call the doctor for skin lesions, urticaria, or angioedema, with or without other symptoms of the infection, especially if there is a previous history of recent exposure to other infected subjects.</p>\",\"PeriodicalId\":21175,\"journal\":{\"name\":\"Revista alergia Mexico\",\"volume\":\"68 2\",\"pages\":\"112-116\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista alergia Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29262/ram.v658i2.841\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v658i2.841","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:描述在COVID-19患者中观察到的最常见的皮肤病,并确定它们的存在是否可以用于建立早期诊断或预测感染的进展。方法:在PubMed/MEDLINE和EMBASE中检索2020年1月1日至11月1日发表的所有论文,检索词集中在“SARS-CoV-2”、“COVID-19”和“皮肤病”。结果:83项研究符合纳入标准。0.2%的患者出现皮肤损伤。最常报道的皮肤病是:斑疹/麻疹样皮疹,荨麻疹和血管性水肿,冻疮样肢端模式和水疱性病变。在研究人员中,对于与感染相关的皮肤疾病的可能诊断或预后价值存在不同的意见。结论:对于因皮肤损害、荨麻疹或血管性水肿而就诊的患者,无论有无其他感染症状,特别是近期有与其他感染者接触史的患者,应考虑诊断为SARS-CoV-2感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Cutaneous manifestations in patients with COVID-19 with significant attention to urticaria].

Objectives: To describe the most frequent dermatological conditions observed in COVID-19 patients and to determine whether their presence could be used to establish an early diagnosis or to predict the progression of the infection.

Methods: There was a review in PubMed/MEDLINE and EMBASE of all the articles that had been published between January 1st and November 1st, 2020, with the search terms focused on "SARS-CoV-2", "COVID-19" and "Skin diseases".

Results: Eighty three studies met the inclusion criteria. Skin lesions have been reported in 0.2 % of the patients. The most frequently reported dermatoses were: maculopapular/ morbilliform rashes, urticaria and angioedema, chilblain-like acral pattern, and vesicular lesions. Among researchers, there are differences of opinion about a possible diagnostic or prognostic value of the skin diseases that are associated to the infection.

Conclusions: It is advisable to consider the diagnosis of SARS-CoV-2 infection in patients who call the doctor for skin lesions, urticaria, or angioedema, with or without other symptoms of the infection, especially if there is a previous history of recent exposure to other infected subjects.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista alergia Mexico
Revista alergia Mexico Medicine-Immunology and Allergy
CiteScore
0.70
自引率
0.00%
发文量
9
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信